Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. China Coronary Stents Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cardiovascular diseases
3.2.1.2. Technological advancements
3.2.1.3. Growing geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies
3.2.2.2. Availability of alternative treatments
3.3. China Coronary Stents Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. China Coronary Stents Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. China Coronary Stents Market Product Movement Analysis
4.3. China Coronary Stents Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Bare Metal Stents (BMS)
4.4.1. Bare metal stents market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Drug-Eluting Stents (DES)
4.5.1. Drug-eluting stents (DES) market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Biodegradable
4.5.2.1. Biodegradable market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Non-Biodegradable
4.5.3.1. Non-biodegradable market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Bioresorbable Vascular Scaffold
4.6.1. Bioresorbable Vascular Scaffold market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Competitive Landscape
5.1. Company/Competition Categorization
5.2. Strategy Mapping
5.3. Company Market Position Analysis, 2023
5.4. Company Profiles/Listing
5.4.1. Abbott
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Medtronic
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Boston Scientific Corporation
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Biotronik
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. MicroPort Scientific Corporation
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. Lepu Medical Technology(Beijing)Co.,Ltd
5.4.6.1. Company overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Biosensors International Ltd
5.4.7.1. Company overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Sino Medical Science and Technology Co., Ltd
5.4.8.1. Company overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Terumo Corporation
5.4.9.1. Company overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Shenzhen Salubris Pharmaceuticals Co., Ltd
5.4.10.1. Company overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives



List of Figures

List of Figures

Fig. 1 China coronary stents market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 QFD modelling for market share assessment
Fig. 9 Market formulation & validation
Fig. 10 Commodity flow analysis
Fig. 11 Market outlook
Fig. 12 Segment snapshot-1
Fig. 13 Competitive landscape snapshot
Fig. 14 Market trends & outlook
Fig. 15 Porter’s five force analysis
Fig. 16 PESTEL analysis
Fig. 17 China coronary stents market: Product outlook key takeaways
Fig. 18 China coronary stents market: Product movement analysis
Fig. 19 Bare metal stents (BMS) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Drug-eluting stents (DES) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Non-biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Bioresorbable vascular scaffold market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Market participant categorization
Fig. 25 China coronary stents market position analysis, 2023
Fig. 26 Strategic framework

List of Tables

List of Tables

Table 1 List of abbreviation
Table 2 China coronary stents market, by product, 2018 - 2030 (USD Million)